Dynamk Capital logo

Dynamk Capital

North America, New York, United States, New York

Description

Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma.

Investor Profile

Dynamk Capital has made 19 investments, with 0 in the past 12 months and 74% as lead.

Stage Focus

  • Series A (58%)
  • Seed (21%)
  • Series B (16%)
  • Series Unknown (5%)

Country Focus

  • United States (84%)
  • Norway (5%)
  • Canada (5%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Medical
  • Life Science
  • Health Care
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Manufacturing
  • Medical Device
  • Bioinformatics
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dynamk Capital frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 2
Embark Ventures
North America, California, United States, Los Angeles
Co-Investments: 2
Third Kind Venture Capital
North America, New York, United States, New York
Co-Investments: 2
Ampersand Capital Partners
North America, Massachusetts, United States, Wellesley
Co-Investments: 2
GRA Venture Fund
North America, Georgia, United States, Atlanta
Co-Investments: 2
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 2
Charles River Laboratories International
North America, Massachusetts, United States, Wilmington
Co-Investments: 2
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1
EC
North America, California, United States, Los Angeles
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Dynamk Capital?

CellFE

Alameda, California, United States

CellFE is a company developing a microfluidics based device to deliver gene-editing molecules.

BiotechnologyHealth Care
Series ASep 27, 2023
Amount Raised: $22,000,000
Lucid Scientific

Atlanta, Georgia, United States

Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.

BiotechnologyMedicalProduct Research
Series ASep 5, 2023
Amount Raised: $7,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 27, 2023
Amount Raised: $20,000,000
Vernal Biosciences

Burlington, Vermont, United States

Vernal Biosciences specializes in high-purity mRNA for research and clinical use.

BiotechnologyLife ScienceMedical
Series AJun 2, 2022
Amount Raised: $21,000,000
Bionter

Riehen, Basel-Stadt, Switzerland

Bionter operates as a company with the purpose of revolutionizing analytical testing for the benefit of people's health.

Health CarePharmaceutical
SeedApr 27, 2022
Amount Raised: $3,000,000
Xcell Biosciences

San Francisco, California, United States

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

BiotechnologyHealth DiagnosticsManufacturingMedicalTherapeutics
Series BJan 19, 2022
Amount Raised: $27,500,000
Curi Bio

Seattle, Washington, United States

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Artificial Intelligence (AI)BiopharmaBiotechnologyMedicalService Industry
Series ADec 29, 2021
Amount Raised: $10,000,000
Virica Biotech

Ottawa, Ontario, Canada

Virica Biotech is a biotechnology company that addresses the unmet needs in production and development to positively change human health.

BiotechnologyHealth CareMedical
Series AOct 4, 2021
Envisagenics

Long Island City, New York, United States

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Artificial Intelligence (AI)BioinformaticsBiotechnologyMachine LearningTherapeutics
Series ASep 29, 2021
Amount Raised: $19,181,626
Vectron Biosolutions

Trondheim, Sor-Trondelag, Norway

Vectron Biosolutions develops and markets vector technologies to biotechnology and life science industries.

BiotechnologyHealth CareLife Science
Series AJun 17, 2021
Amount Raised: $2,700,000